Key statistics
On Friday, Transmedics Group Inc (TMDX:NMQ) closed at 129.84, -16.77% below its 52-week high of 156.00, set on Dec 02, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 127.50 |
|---|---|
| High | 132.22 |
| Low | 127.50 |
| Bid | 127.50 |
| Offer | 135.00 |
| Previous close | 128.52 |
| Average volume | 590.77k |
|---|---|
| Shares outstanding | 34.17m |
| Free float | 33.17m |
| P/E (TTM) | 53.99 |
| Market cap | 4.39bn USD |
| EPS (TTM) | 2.38 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
- TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
- TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial
- TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts
- TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
- TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference
More ▼
